VANCOUVER, BC — Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy aging, has initiated a program aimed at advancing its topical treatments for… Read More
Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old 68% of children on a higher dose of Dupixent achieved histological disease… Read More
The PRAME (EPR20330) Antibody evaluates PRAME protein expression from patients with suspected melanoma. Understanding if the PRAME protein is expressed helps enable more informed clinical decisions and may improve patient… Read More
Date: February 8 to September 13, 2023 Venue: Virtual and in person at MATTER Healthcare Incubator Location: Chicago, United States of America Target Audience: Canadian entrepreneurs and innovators with a product or technology in… Read More
Integrating Research Innovation and Health Care Research has a profound impact on patient care and population health, and leads to a greater understanding of diseases, life-saving treatments and preventative strategies… Read More
